Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) EPS (Weighted Average and Diluted): 2019-2024

Historic EPS (Weighted Average and Diluted) for Anaptysbio (ANAB) over the last 6 years, with Dec 2024 value amounting to -$5.12.

  • Anaptysbio's EPS (Weighted Average and Diluted) rose 145.61% to $0.52 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.76, marking a year-over-year increase of 54.61%. This contributed to the annual value of -$5.12 for FY2024, which is 15.79% up from last year.
  • As of FY2024, Anaptysbio's EPS (Weighted Average and Diluted) stood at -$5.12, which was up 15.79% from -$6.08 recorded in FY2023.
  • In the past 5 years, Anaptysbio's EPS (Weighted Average and Diluted) registered a high of -$0.73 during FY2020, and its lowest value of -$6.08 during FY2023.
  • Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was -$5.12 (2024), whereas its average is -$5.26.
  • Per our database at Business Quant, Anaptysbio's EPS (Weighted Average and Diluted) skyrocketed by 79.72% in 2020 and then crashed by 189.04% in 2021.
  • Yearly analysis of 5 years shows Anaptysbio's EPS (Weighted Average and Diluted) stood at -$0.73 in 2020, then plummeted by 189.04% to -$2.11 in 2021, then tumbled by 116.59% to -$4.57 in 2022, then crashed by 33.04% to -$6.08 in 2023, then grew by 15.79% to -$5.12 in 2024.